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Abstract
Background: Following the recent transfer of all accepted species of Penicillium subgenus Biverticillium to
Talaromyces (including Talaromyces marneffei, formerly Penicillium marneffei), Penicillium species are becoming
increasingly rare causal agents of invasive infections. Herein, we present a report of a type 2 diabetes patient with a
fungus ball in the respiratory tract caused by Penicillium capsulatum.
Case presentation: A 56-year-old Chinese female gardener with a 5-year history of type 2 diabetes presented at
the Shanghai Changzheng Hospital with fever, a cough producing yellow-white sputum, and fatigue. The
therapeutic effect of cefoxitin was poor. An HIV test was negative, but the β-D-glucan test was positive (459.3 pg/
ml). Chest radiography revealed a cavitary lesion in the left upper lobe, and a CT scan showed globate cavities with
a radiopaque, gravity-dependent ball. The histopathologic features of the tissue after haematoxylin-eosin staining
showed septate hyphae. The fungus was isolated from the gravity-dependent ball and identified as Penicillium
capsulatum based on the morphological analysis of microscopic and macroscopic features and on ribosomal
internal transcribed spacer sequencing. After surgery, the patient was cured with a sequential treatment of
fluconazole 400 mg per day for 90 days and caspofungin 70 mg per day for 14 days.
Conclusions: Although the prognosis is often satisfactory, clinicians, mycologists and epidemiologists should be
aware of the possibility of infection by this uncommon fungal pathogen in diabetes patients, since it may cause
severe invasive infections in immunocompromised hosts such as diabetes and AIDS patients.
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Background
Penicilliosis is an invasive fungal infection that primarily
occurs in the southeast and eastern regions of Asia,
including Thailand, northeast India, China, Hong Kong,
Laos, Cambodia, Malaysia, Myanmar, Vietnam and
Taiwan [1]. Penicillium marneffei causes the vast major-
ity of penicillioses, especially in immunosuppressed
hosts such as AIDS patients and otherwise healthy indi-
viduals [1-3]. This species was recently transferred to
the genus Talaromyces together with other Penicillium
species belonging to the subgenus Biverticillium [4].
Thus, excluding Talaromyces marneffei (formerly known
as P. marneffei), systemic infections caused by Penicillium
species are becoming increasingly rare. Currently, approxi-
mately 300 species are grouped within the genus Penicil-
lium, and only a limited number are associated with
invasive fungal infections [5]. The majority of Penicillium
species are saprobic and commonly occur in soil; however,
some species are known for their positive or negative
effects on humans. The positive impacts include their use
in food fermentation and the production of drugs, and the
negative effects are related to the production of myco-
toxins, the induction of hypersensitivity reactions (e.g.,
asthma and extrinsic allergic alveolitis) and the infection
of humans. Presently, China has an increasing burden of
diabetes (92.4 million adults above the age of 20) [6], and
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diabetes mellitus is considered to be a significant suppres-
sor of the human immune system. Herein, we report a
case of a 56-year-old patient with type 2 diabetes who de-
veloped a fungus ball in the left lung caused by Penicillium
capsulatum. The diagnosis, treatment and clinical import-
ance of P. capsulatum are discussed.
Case presentation
A 56-year-old Chinese female gardener presented to the
Shanghai Changzheng Hospital with fever, a cough produ-
cing yellow-white sputum and fatigue. The therapeutic ef-
fect of cefoxitin (4000 mg/day, 14 days) was poor. She had
a 5-year history of type 2 diabetes with effective treatment
by insulin injection but no history of tuberculosis, chronic
obstructive pulmonary disease, asthma or other under-
lying immunosuppressive diseases. A test for the human
immunodeficiency virus was negative, but the β-D-glucan
test was positive (459.3 pg/ml). Chest radiography revealed
a cavitary lesion in the left upper lobe, and chest com-
puted tomography (CT) showed globate cavities with a
radiopaque, gravity-dependent ball (Figure 1). Based on
these data, the causal agent of the infection was initially
thought to be Aspergillus spp. because of the fungus ball’s
resemblance to an aspergilloma caused by species such as
Aspergillus fumigatus. Histologic sections of the tissue
were stained with haematoxylin and eosin (HE) and
showed septate fungal hyphae (Figure 2). Specimens from
the gravity-dependent ball were obtained, and the fungal
strain was identified as Penicillium capsulatum via micro-
and macro-morphology examination and molecular se-
quence analysis. For macroscopic examination, the culture
was grown for 7 days at 25°C on malt extract agar (MEA),
Czapek yeast extract agar (CYA) and yeast extract sucrose
agar (YES), and the fungus exhibited restricted growth on
all media (13–17 mm) with grey-green sporulating col-
onies. Growth on MEA plates incubated at 30°C and 37°C
was faster (17–25 mm) than at 25°C. Microscopy analysis
of the colonies grown on MEA showed short, smooth-
walled, monoverticillate Penicillium conidiophores. The
conidia were smooth walled and ellipsoid to slightly cy-
lindrical and measured 3.5–4.5 × 2.5–3.0 μm (Figure 3).
Molecular characterisation of the strain was performed
by PCR amplification and sequencing of the ribosomal
internal transcribed spacer region as described by
Houbraken et al. [7]. The isolate was deposited in the
CBS collection under the accession number CBS
134186, and newly generated sequences were deposited
in GenBank. Figure 4 shows that the strain belongs to
Penicillium section Ramigena [5] and that it is closely
related to the type culture of Penicillium capsulatum,
CBS 301.48. So we diagnosed this infection as Penicil-
lioma which we created particularly. After pulmonary
lobectomy, the patient was cured sequentially by
Figure 1 Chest computed tomography showing a fungus ball in the left upper lobe of the lung.
Figure 2 Histologic section of a specimen taken from the
fungus ball showing septate fungal hyphae (H&E strain)
(magnification × 400).
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treatment of fluconazole (400 mg/day, 90 days) and
caspofungin (70 mg/day, 14 days).
Furthermore, to confirm the antifugal susceptibility
in vitro, the clinical isolate CBS 134186 was, together
with other environmental P. capsulatum isolates, tested
in vitro against seven antifungal agents (amphotericin
B, voriconazole, itraconazole, ketoconazole, fluconazole,
5-fluorocytosine, and caspofungin) using the CLSI
M38-A2 broth microdilution method [8]. The results of
this analysis are summarized in Table 1 and show that
all tested P. capsulatum strains have a low minimal ef-
fective concentration (MEC) to caspofungin and a high
minimal inhibitory concentration (MIC) to fluconazole.
No substantial difference for all seven antifungal agents
Figure 3 Penicillium capsulatum CBS 134186. A. 7 days old culture on MEA incubated at 25°C. B. 7 days old culture on MEA incubated at 37°C.
C–E. Conidiophores. F. Conidia. Scale bars = 10 μm.
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in antifungal susceptibility was observed between CBS
134186 and the P. capsulatum strains isolated from
environmental sources (Table 1).
Conclusions
As reviewed by Lyratzopoulos et al. [9], only fifteen
cases of invasive infections caused by species other than
T. marneffei have been linked to the Penicillium genus
worldwide. More recently, other Penicillium species,
such as P. chrysogenum, P. piceum and P. purpurogenum,
were found to be associated with these infections [10-13].
However, when applying the current taxonomic concepts
[4], the latter two Penicillium species now belong to the
Talaromyces genus, namely T. purpurogenus and T. piceus.
Penicillium capsulatum, a rare species belonging to
Penicillium section Ramigena [5], is considered a useful
microorganism in the paper manufacturing industry
[14,15], but it has never been previously recognised as a
causative agent of invasive infection in humans. One of
the pathogenicity factors of Penicillium species causing
invasive infections is its ability to grow at 37°C [16]. The
majority of Penicillium species have a maximum growth
temperature below 37°C; however, exceptions include
P. chrysogenum, P. citrinum, P. decumbens and P. janthinel-
lum, and some of these species are causal agents of invasive
infections, as stated above [10,16]. Our clinical P. capsula-
tum isolate grows well on MEA, CYA and YES incubated
at 37°C, and growth at 30°C and 37°C was faster (17–
25 mm) than at 25°C (13–17 mm). In our opinion, both
the fungus’s ability to grow at 37°C and the patient’s dia-
betes mellitus contributed to the presence of the fungus
ball in the patient. Despite the clinical strain can be con-
sidered resistant to fluconazole, the treatment seemed to
be effective in vivo in this case. We believe that combined
antifungal drug (caspofungin + fluconazole), resection of
the primary lesion, and the patient’s immune status are
important for satisfactory prognosis. Additionally, there
is no substantial difference in antifungal susceptibilities
between the P. capsulatum strains isolated from envir-
onmental sources and the CBS 134186 isolate (Additional
file 1: Table S1).
In the present study, we used phenotypic characters
and ITS sequences for identification. Identification
based solely on the phenotype is often difficult and
requires well-trained staff. Currently, molecular-based
techniques, especially DNA sequencing, are frequently
used for identification, and the ITS region is accepted
as the primary fungal barcode [17]. This study shows
that P. capsulatum can be identified based on ITS se-
quence data alone. In contrast, other Penicillium (and
Aspergillus) species cannot be unambiguously identi-
fied by ITS sequencing alone, and partial β-tubulin or
calmodulin sequences are required to ensure correct
species identification [7]. The initial results based on
the chest radiography and CT scan showed structures
resembling an aspergilloma caused by Aspergillus. Peni-
cillium and Aspergillus are sister genera and belong to
the family Aspergillaceae [12]. This close relationship
may explain their resemblance in chest radiographs and
CT scans. It should be noted that Aspergillus species
cause most pulmonary mycetomas, and other phylo-
genetically unrelated fungi including Fusarium, Mucor
Figure 4 The best-scoring Maximum Likelihood tree with the
highest log likelihood (−1269.6815) is presented and shows
that the strain isolated from gravity-dependent ball (in bold) is
similar to the type of P. capsulatum CBS 301.48. The phylogram
was constructed using MEGA5.1 and is based on ITS sequences. The
bootstrap percentages using Maximum Parsimony (MP) and
Maximum Likelihood (ML) (MP/ML) are shown at the nodes. Values
less than 70% support are not shown; the tree is rooted with
Penicillium glabrum CBS 125543 (T = Type; NT = Neotype).
Table 1 Antifungal susceptibilities of P. capsulatum isolates from strains isolated from environmental sources and CBS
134186 (μg/mL)
Amphotericin B Voriconazole Itraconazole Ketoconazole Fluconazole 5-fluorocytosine Caspofungin
ATCC10420 1 1 0.25 0.125 >64 16 1
ATCC48735 1 0.5 0.25 0.0625 >64 32 1
CBS134186 0.5 0.5 0.25 0.0625 >64 32 1
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and Paecilomyces, can cause similar clinical manifesta-
tions [18].
In summary, Penicillium capsulatum produced a
pulmonary fungus ball in a female patient with type 2
diabetes but was cured with combined surgical and an-
tifungal treatment. An aggressive diagnostic and thera-
peutic strategy should be pursued for such infections.
To our knowledge, this is the first report of a pulmonary
infection caused by P. capsulatum worldwide; thus, this
report expands our understanding of the pathogenicity of
the genus Penicillium in this age of global warming [19].
Clinicians, mycologists and epidemiologists should be
aware of the possibility of infection by uncommon fungal
pathogens in patients because emerging pathogenic fungi
are increasingly recognised as major threats to human
health [19,20].
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